Cargando…
A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure
Background: High-flow nasal cannula (HFNC) has been recommended as a suitable choice for the management of coronavirus disease 2019 (COVID-19) patients with acute hypoxemic respiratory failure before mechanical ventilation (MV); however, delaying MV with HFNC therapy is still a dilemma between the t...
Autores principales: | Xu, Jiqian, Yang, Xiaobo, Huang, Chaolin, Zou, Xiaojing, Zhou, Ting, Pan, Shangwen, Yang, Luyu, Wu, Yongran, Ouyang, Yaqi, Wang, Yaxin, Xu, Dan, Zhao, Xin, Shu, Huaqing, Jiang, Yongxiang, Xiong, Wei, Ren, Lehao, Liu, Hong, Yuan, Yin, Qi, Hong, Fu, Shouzhi, Chen, Dechang, Zhang, Dingyu, Yuan, Shiying, Shang, You |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793962/ https://www.ncbi.nlm.nih.gov/pubmed/33425951 http://dx.doi.org/10.3389/fmed.2020.607821 |
Ejemplares similares
-
Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China
por: Xu, Jiqian, et al.
Publicado: (2020) -
Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study
por: Wu, Yongran, et al.
Publicado: (2020) -
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
por: Yang, Xiaobo, et al.
Publicado: (2020) -
Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study
por: Tang, Yun, et al.
Publicado: (2023) -
Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study
por: Tang, Yun, et al.
Publicado: (2022)